OCT 11, 2020 4:57 PM PDT

Targeting neoantigens to improve immunotherapies

Neoantigens are extremely small biomarkers forming from cancer mutations that demonstrate the presence of cancerous cells. Scientists say that expanding our knowledge of neoantigens could improve the way we develop anticancer treatments, unlocking more efficient immunotherapies with fewer side effects. New research from the Parker Institute for Cancer Immunotherapy (PICI) and the Cancer Research Institute encompasses an initiative named the Tumor Neoantigen Selection Alliance (TESLA) that aims to promote interdisciplinary work in this field.

The study, published in the journal Cell, highlights the exciting developments in personalized precision medicine. The TESLA initiative team says their findings demonstrate improved insights on how neoantigens present on the cancer cell and how they are recognized by the immune system.

"Until now, neoantigen prediction has been a black box. We had hints at what features might be important. The data model out of TESLA is the first to identify these five features as significant," said co-senior author on the paper and professor Robert D. Schreiber, Ph.D., at Washington University School of Medicine in St. Louis.

The data model from the initiative was developed through an advanced computational analysis that looked at which particular neoantigens were most likely to generate an immune response. The model proved capable of accurately predicting 75% of effective neoantigen targets and eliminating 98% of ineffective ones.

"Our aim is that data produced from TESLA becomes the reference standard when developing a new neoantigen-based treatment," said corresponding author Daniel Wells, Ph.D., principal data scientist at PICI. "If every method, old and new, used the data to benchmark their predictions, the whole field would be able to collaborate and iterate on new methods much more quickly."

Photo: Pixabay

TESLA has made the model and accompanying dataset free and open access to the research community with the intention of facilitating further investigation into personalized therapy development.

"This research has the potential to improve drug makers' and researchers' mathematical algorithms. It can prioritize antigens most likely to be present on each patient's cancer and most visible to the immune system while deprioritizing the ones that aren't. That means better individualized treatments for patients," said Lisa Butterfield, Ph.D., vice president of research and development at PICI. "We're excited to see where the field takes these findings."

Sources: Cell, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 06, 2020
Cancer
Focal HIFU ablation improves prostate cancer patients' quality of life
SEP 06, 2020
Focal HIFU ablation improves prostate cancer patients' quality of life
Research published in The Journal of Urology offers an alternative to invasive prostate cancer treatments like surg ...
SEP 23, 2020
Cancer
Can Increased Pain Indicate Oral Cancer?
SEP 23, 2020
Can Increased Pain Indicate Oral Cancer?
The human body has many ways of letting you know something is wrong. It can send signals to tell you that you are hungry ...
OCT 06, 2020
Cannabis Sciences
Cannabis Use May Reduce Cancer Risk by 10%
OCT 06, 2020
Cannabis Use May Reduce Cancer Risk by 10%
A recent meta-analysis of 34 studies found that cannabis use may decrease one’s risk of developing certain kinds o ...
OCT 14, 2020
Cancer
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
OCT 14, 2020
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
Cold atmospheric plasma is a relatively new technique that utilizes a tool that generates a sort of plasma scalpel, exce ...
OCT 12, 2020
Cancer
Urine analysis is better at detecting bladder cancer than urine cytology
OCT 12, 2020
Urine analysis is better at detecting bladder cancer than urine cytology
In a study published recently in the American Association for Cancer Research journal Clinical Cancer Research, scientis ...
OCT 25, 2020
Cell & Molecular Biology
Revealing More About the Genetics of Ewing Sarcoma
OCT 25, 2020
Revealing More About the Genetics of Ewing Sarcoma
Ewing sarcoma is a rare kind of cancer that tends to impact young people and occurs in bones or the tissue around them. ...
Loading Comments...